The molecular core facility provides services to investigators that involve either short- or long-term use of molecular techniques. It is our experience that two types of investigators are interested in our services. The first type of investigator is one who is not currently equipped to conduct experiments involving molecular biology, but recognize the advantages that can be derived by studying their experimental system on a molecular level. Investigators in this group may not be able or interested in making the investment in the equipment and supplies that are required to utilize molecular techniques. For example, this investigator may need to evaluate gene expression in their experimental system. The second type of investigator is one who is already active in molecular biology, but appreciates the advantage in both time and research funds to take advantage of our services. This type of investigator may recognize that it is possible to utilize the Molecular Core and continue to carry out other molecular studies without the need to stop to prepare molecular constructs, or measure gene expression, with precious limited resources of their own. An example would be an investigator who would like to stably express an epitope-tagged form of one of the opioid receptors in a convenient cell line. An additional example would be an investigator who is interested in measuring gene expression in vivo following drug treatment, and would like to have information about the activity of a gene which is likely to be involved in a regulatory signal transduction pathway. We provide services for investigators who span a variety of disciplines, and we carry out our work either in direct collaboration with the investigator (and their colleagues), or we carry out our work independently and pass along the product of our work to the investigator (e.g., in the form of a molecular construct, or in the form of a stably-transfected cell line).

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA013429-17
Application #
9065525
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
17
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Ward, Sara Jane; Castelli, Francesca; Reichenbach, Zachary W et al. (2018) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sci 195:1-5
Liu, Jeffrey J; Sharma, Kirti; Zangrandi, Luca et al. (2018) In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360:
Oliver, Chicora F; Simmons, Steven J; Nayak, Sunil U et al. (2018) Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75-79
Zewde, Ashenafi Mebratu; Yu, Frances; Nayak, Sunil et al. (2018) PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects. J Neurosci Methods 293:284-288
Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L et al. (2018) Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation. J Neuroinflammation 15:25
Ramirez, Servio H; Andrews, Allison M; Paul, Debayon et al. (2018) Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. Fluids Barriers CNS 15:19
Brailoiu, Eugen; Barlow, Christine L; Ramirez, Servio H et al. (2018) Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. Neuroscience 377:105-113
Barbe, Mary F; Massicotte, Vicky S; Assari, Soroush et al. (2018) Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism. Bone 110:267-283
Gentile, Taylor A; Simmons, Steven J; Barker, David J et al. (2018) Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol 23:247-255
Hicks, Callum; Huang, Peng; Ramos, Linnet et al. (2018) Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats. ACS Chem Neurosci 9:1327-1337

Showing the most recent 10 out of 343 publications